An intervention program for ADHD in patients with substance use disorders: Preliminary results of a field trial

Journal of Substance Abuse Treatment

Volumn 30, Issue 3, 2006, Pages 253-259

  Goossensen, M Anne ^a   van de Glind, Geurt ^b   Carpentier, Pieter Jan ^c   Wijsen, Riek M A ^d   van Duin, Daniëlle ^b   Kooij, J J Sandra ^e  

^a Erasmus University Rotterdam   (Netherlands)

^b NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^c Network for Addiction Treatment Services   (Netherlands)

^d Regional Addiction Treatment Centre Gelderland   (Netherlands)

^e PsyQ   (Netherlands)

Author keywords

Attention deficit hyperactivity disorder; Comorbidity; Substance use disorder

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; ATOMOXETINE; IMIPRAMINE; METHYLPHENIDATE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CENTER; NETHERLANDS; PATIENT REFERRAL; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIC TREATMENT; QUESTIONNAIRE; SCREENING; SELF REPORT; SUBSTANCE ABUSE;

ACTIVITIES OF DAILY LIVING; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CLINICAL PROTOCOLS; EDUCATION; FAMILY; HUMANS; INTERVIEW, PSYCHOLOGICAL; PEER GROUP; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; SOCIAL SUPPORT; SUBSTANCE-RELATED DISORDERS;

EID: 33645986970     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2005.12.004     Document Type: Article

References (29)

1. Biederman J., Faraone S.V., and Spencer T. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry 150 (1993) 1792-1798
2. Biederman J., Wilens T., Mick E., Spencer T., and Faraone S.V. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 104 (1999) 1-5
3. Castaneda R., Levy R., Hardy M., and Trujillo M. Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults. Psychiatric Services 51 (2000) 169-171
4. Clure C., Brady K.T., Saladin M.E., Johnson R., and Rittenbury M. Attention-deficit/hyperactivity disorder and substance use: Symptom pattern and drug choice. American Journal of Drug and Alcohol Abuse 25 (1999) 441-448
5. Ferdinand R.F., and Verhulst F.C. The prevalence of self-reported problems in young adults from the general population. Social Psychiatry and Psychiatric Epidemiology 31 (1996) 10-20
6. Kessler R.C. Prevalence of adult ADHD in the United States: Results from the National Comorbidity Survey Replication (NCS-R). Presented at the 2004 annual meeting of the American Psychiatric Association (2004)
7. King V.L. Attention deficit disorder and treatment outcome in opioid abusers entering treatment. Journal of Nervous and Mental Disease 187 (1999) 487-495
8. Kooij J.J.S. ADHD bij volwassenen. Inleiding in Diagnostiek en behandeling. 2nd ed. (2003), Swets & Zeitlinger Publishers, Lisse
9. Kooij J.J.S., Buitelaar J.K., and van Tilburg W. Voorstel voor diagnostiek en behandeling van aandachtstekortstoornis met hyperactiviteit (ADHD) op volwassen leeftijd. Tijdschrift voor Psychiatrie 41 (1999) 349-358
10. Kooij J.J.S., Burger H., Boonstra A.M., van der Linden P.D., Kalma L.E., and Buitelaar J.K. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder (ADHD). A randomised placebo-controlled double-blind cross-over trial. Psychological Medicine 34 (2004) 973-981
11. Kooij J.J.S., van den Oord E.J., Buitelaar J.K., Furer J.W., Rijnders C.A., and Hodiamont P.P. Internal and external validity of attention-deficit/hyperactivity disorder in a population-based sample of adults. Psychological Medicine 35 (2005) 817-827
12. Levin F.R., Evans S.M., and Kleber H.D. Practical guidelines for the treatment of substance abusers with adult attention-deficit hyperactivity disorder. Psychiatric Services 50 (1999) 1001-1003
13. Levin F.R., Evans S.M., McDonnel D.M., and Kleber H.D. Methylphenidate treatment for cocaine abusers with adult attention-deficit hyperactivity disorder. A pilot study. Journal of Clinical Psychiatry 58 (1998) 300-305
14. Lynskey M.T., and Hall W. Attention Deficit Hyperactivity Disorder and substance use disorders: Is there a causal link?. Addiction 96 (2001) 815-822
15. Mattes J.A., Boswell L., and Oliver H. Methylphenidate effects on symptoms of attention deficit disorder in adults. Archives of General Psychiatry 41 (1984) 1059-1063
16. Mc Dermott S.P. Cognitive therapy in adults with ADHD. In: Brown T.E. (Ed). Attention-deficit disorders and comorbidities in children, adolescents and adults (2000), American Psychiatric Press, Arlington, VA 361-387
17. Sackett D.L., Straus S.E., Richardson W.S., Rosenberg W., and Haynes R.B. Evidence-based medicine. How to practise and teach EBM (2000), Churchill Livingstone, Edinburgh
18. Safren S.A., Otto M.W., Sprich S., Winett C.L., Wilens T.E., and Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behaviour Research and Therapy 43 (2005) 831-842
19. Schubiner H., Saules K.K., Arfken C.L., Johanson C.E., Schuster C.R., Lockhart N., et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Experimental and Clinical Psychopharmacology 10 (2002) 286-294
20. Schubiner H., Tselepsis A., Isaacson L.H., Warbasse M., and Musial J. The dual diagnosis of Attention-Deficit/Hyperactivity Disorder and substance abuse: Case reports and literature review. Journal of Clinical Psychiatry 56 (1995) 146-150
21. Schubiner H., Tzelepsis A., Milberger S., Lockhart N., Kruger M., Kelley B.J., et al. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. Journal of Clinical Psychiatry 61 (2000) 244-251
22. Somoza E.C., Winhusen T.M., Bridge T.P., Rotrosen J.P., Vanderburg D.G., Harrer J.M., et al. An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. Journal of Addiction Disorders 23 (2004) 77-92
23. Spencer T., Wilens T.E., Biederman J., Faraone S.V., Ablon S., and Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Archives of General Psychiatry 52 (1995) 434-443
24. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. Archives of General Psychiatry 56 (1999, Dec) 1073-1086
25. van de Glind G., Eland A., and Janssen M. ADHD en Verslaving. Een literatuuronderzoek naar de samenhang tussen ADHD en verslavingsproblemen. Maandblad Geestelijke volksgezondheid (2001) 537-555
26. Wilens T.E. Drug therapy for adults with attention-deficit hyperactivity disorder. Drugs 63 (2003) 2395-2411
27. Wilens T.E. Attention-deficit/hyperactivity disorder and the substance use disorders: The nature of the relationship, subtypes at risk, and treatment issues. Psychiatric Clinics of North America 27 (2004, June) 283-301
28. Wilens T.E., Faraone S.V., Biederman J., and Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111 (2003, January) 179-185
29. Wilens T.E., Haight B.R., Horrigan J.P., Hudziak J.J., Rosenthal N.E., Connor D.F., et al. Buproprion XL in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled study. Biological Psychiatry 57 (2005) 793-801